Therefore, we were not able to investigate whether the C1QTNF6 polymorphism alone or in combination with other genetic variants could predict the appearance of autoantibodies, the progression to clinical T1D or the fast decline in beta-cell function in Chinese patients. This evidence concerns the gene C1QTNF6 and type 1 diabetes mellitus.